Reports mentioning Insilico Medicine
An artificial intelligence-designed drug named rentosertib has demonstrated potential in reversing the effects of aging, according to early clinical trial results published this week in Nature Biotechnology. Insilico Medicine, a company specializing in AI-driven drug discovery and development, created…
An AI platform named PandaOmics, developed by Insilico Medicine, has demonstrated its capability to discover novel biological targets and accelerate drug development by identifying a new protein target for pain management.
Reflect Orbital is planning to launch a test satellite later this year, which will deploy an 18-by-18-meter mirror in orbit, as part of a larger initiative to deploy up to 50,000 larger satellites capable of reflecting sunlight to Earth…
Biotech companies are increasingly leveraging generative artificial intelligence to accelerate drug discovery, with Insilico Medicine being a prominent example. Insilico Medicine utilized its AI platform to propose a novel drug candidate for pulmonary fibrosis, a condition characterized by the scarring…